Goran Ando

Dr. Goran Ando is a high-net-worth investor based in London, United Kingdom. He serves as Chairman of the Board, Nomination Committee and Remuneration Committee at Novo Nordisk. He was deputy Chief Executive Officer and President of R&D with additional responsibilities for manufacturing, IT and development at Pharmacia and he later served as Chief Executive Officer of Celltech Group.